Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
 
 

Kappa Psi Pharmaceutical Fraternity Fall Meeting_Treatment of Patients with Type 2 DM and CKD: Have Times Changed?


Date: Nov 2, 2020 08:00 PM - 09:30 PM

Fee

$0.00

CE Hours

1.50

CE Units

0.150

Registration closes on Dec 28, 2020 10:30 PM

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
Accreditation Statement: Howard University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Joint Provider(s)

Kappa Psi Pharmaceutical Fraternity - Mountain East Province

 

 

 

   

Objectives

  • Explain the importance of controlling diabetic kidney disease
  • Outline treatment modalities for patients with Type 2 diabetes mellitus and chronic kidney disease (CKD)
  • Identify the clinical trial findings that led to supporting the use of sodium glucose co-transporter-2 inhibitors (SGLT-2) in diabetic patients with chronic kidney disease

Speaker(s)/Author(s)

Dr. Christyn Mullen-Lee, PharmD, BCACP
Ambulatory Care Clinical Pharmacy Specialist, North Texas Veterans Affairs Medical Center

Activity Number

0010-9999-20-051-L01-P
Date: 11/02/20
Time: 08:00 PM - 09:30 PM

CE Hours

1.50